NCT02180997View on ClinicalTrials.gov

Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
LUTSBenign Prostatic HyperplasiaOveractive Bladder
Interventions
DRUG

Tamsulosin

Tamsulosin and solifenacin: Tamsulosin 0.4mg, once daily

DRUG

Solifenacin

Tamsulosin and solifenacin: Solifenacin 10 mg, once daily

DRUG

Tamsulosin and solifenacin

Tamsulosin and solifenacin: Tamsulosin 0.4mg, once daily, Solifenacin 10 mg, once daily

Trial Locations (1)

110-744

Seoul National University Hospital(SNUH), Seoul

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY

NCT02180997 - Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin | Biotech Hunter | Biotech Hunter